Back to results
US 12,637,414 B2Granted
Arylamides and methods of use thereof
AssigneeGenzyme Corporation
InventorsJunkai Liao, Mark Munson, Zhongli Gao, Gregory Hurlbut, Hans Peter Nestler, Ingrid Mechin, Joseph Kim, Martin Smrcina, Nina Ma, Ronghua Li, Ryan Hartung, William Bock, Bertrand Vivet
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.
Claims45
A compound of formula I:
- or a pharmaceutically acceptable salt thereof, wherein:
- A is selected from
- wherein * marks the point of attachment to Y and ** marks the point of attachment to —C(O)—;
- Z1, Z2, and Z3 are each independently CR10 or N;
- Z4 and Z5 are each independently O or S;
- Y is a bond, —NR3—, —O—, —S—, or —C(R4)2—;
- E is C2-6-alkynyl, C3-9-cycloalkyl, C4-9-cycloalkenyl, C6-10-aryl, 3-10 membered heteroaryl, or a 3-9 membered heterocycloalkyl, each of which is optionally substituted with one, two, three, four, or five occurrences of R5;
- V is —C(O)—O—R7;
- R1 is adamantyl optionally substituted with one, two, three, four, or five occurrences of Rd;
- each Rd is independently —OH, —NH2, —N═CH(NH2)2, halo, C1-4-alkyl, —O—C1-6-alkyl, —O—C1-6-alkyl-OH, —C1-6-alkyl-OH, —C1-6 haloalkyl, —O—C1-6-haloalkyl, —C1-6-alkyl-OH, —C1-6-alkyl-COOH, —C1-6-alkyl-C(O)2—C1-6-alkyl, —O—C1-6-alkyl-C(O)—C1-6-alkyl, —O—C1-6-alkyl-O—C1-6-alkyl, —O—C1-6-alkyl-C(O) OH, —O—C1-6-alkyl-C(O)O—C1-6-alkyl, or-O—C1-6-alkyl-S(O)—O—C1-6-alkyl;
- each R2 is independently halo, —OH, —NH2, —N—(C1-6-alkyl)2, C1-6-alkyl, C1-6-haloalkyl, —O—C1-6-alkyl, —O—C1-6-alkyl-OH, —O—C1-6-alkyl-O—C1-6-alkyl, —O—C2-6-alkenyl, or C6-10-aryl;
- R3 is hydrogen or C1-6 alkyl;
- R4 is independently hydrogen or C1-6 alkyl;
- each R5 is independently halo, —CN, —NO2, —SF3, —SF5, C1-6-alkyl, C2-6-alkenyl, C1-6-haloalkyl, —O—C1-6-alkyl, —O—C1-6-haloalkyl, —C1-6-alkyl-OH, —C(O)—O—C1-6-alkyl, —S—C1-6alkyl, —S—C1-6-haloalkyl, —S(O)2-C1-6-alkyl, —S(O)2-C1-6-haloalkyl, C6-10-aryl, or —C3-9-cycloalkyl;
- or two R5 moieties, taken together with the atoms to which they are attached, form a 3-9 membered heterocycloalkyl ring, wherein each aryl, cycloalkyl, or heterocycloalkyl is substituted with one, two, or three occurrences of R8;
- each R6 and R10 is independently hydrogen, halo, C1-6-alkyl, or —O—C1-6-alkyl;
- R7 is hydrogen, C1-6-alkyl, C6-10-aryl, or benzyl;
- each R8 is independently halo or C1-6-alkyl;
- R9 is hydrogen, C1-6 alkyl or oxo;
- and
- m is 0, 1, or 2.
18 more elements
A compound selected from:
- Com-
- pound
- Structure
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- or a pharmaceutically acceptable salt thereof.
138 more elements
Dependencies are inferred from the claim text.